IMMU-08. reMATCH PROTOCOL: PHASE II STUDY OF EX-VIVO EXPANDED AUTOLOGOUS TUMOR SPECIFIC LYMPHOCYTE TRANSFER (X-ALT) + TOTAL TUMOR RNA DC VACCINE (TT-RNA DC) DURING RECOVERY FROM MYELOABLATIVE CHEMOTHERAPY (MAC) AND PERIPHERAL BLOOD STEM CELL (PBSC) RESCUE OR NON-MYELOABLATIVE CHEMOTHERAPY (NMAC) AND PBSC IN PATIENTS (PTS) WITH RECURRENT PNET (R-PNET)

Authors: Sridharan Gururangan, Eugene Hwang, Girish Dhall, Oleg Yegorov, Lance Governale, Jason Blatt, Biljana Horn, Duane Mitchell

Published: 2020-12-04

DOI: 10.1093/neuonc/noaa222.364

Source: Full article